SARC041 - Phase 3 Randomized double blind study of Abemaciclib versus Placebo in patients with advanced dedifferentiated Liposarcoma (Appendix 10) Grant uri icon

Overview

date/time interval

  • January 1, 2022 - June 30, 2028

sponsor award ID

  • SARC 223132-01